Reproductive Medicine and Biology, an esteemed journal published by WILEY, stands at the forefront of advancements in the field of reproductive health and associated biological sciences. With an impact factor that underscores its relevance—ranking in Q1 for Reproductive Medicine and Q3 in Cell Biology—this journal is distinguished by its commitment to disseminating high-quality, peer-reviewed research since its transition to Open Access in 2002. Based in Japan, the journal caters to a global audience, providing vital insights into reproductive biology, therapeutics, and innovative practices. With Scopus rankings placing it at #22 out of 90 in Reproductive Medicine and a commendable percentile ranking, Reproductive Medicine and Biology aims to foster dialogue and knowledge transfer among researchers, professionals, and students, paving the way for breakthroughs in understanding reproductive health.

Human Reproduction Open, published by Oxford University Press, is a prestigious open-access journal dedicated to advancing the field of reproductive health and medicine since its inception in 2017. With an E-ISSN of 2399-3529, the journal provides a vital platform for researchers, clinicians, and academics to disseminate innovative findings in obstetrics, gynecology, and reproductive medicine. It is recognized for its impactful contributions, holding an impressive rank of #3 out of 209 in Medicine - Obstetrics and Gynecology, #2 out of 90 in Medicine - Reproductive Medicine, and #1 out of 21 in Medicine - Embryology, placing it in the top percentiles of its respective categories. The open-access model ensures that research is freely accessible, fostering collaboration and knowledge sharing among professionals and students alike. With a commitment to high-quality, peer-reviewed publications, Human Reproduction Open plays a crucial role in shaping the future of reproductive health research and practice, serving as an essential resource for those dedicated to improving outcomes in this dynamic field.

Reproduction and Fertility is a premier academic journal published by BIOSCIENTIFICA LTD, dedicated to advancing knowledge in the fields of reproductive sciences, obstetrics, gynecology, and related areas. Established with a focus on delivering high-quality research, this journal has quickly ascended in prominence, achieving a commendable Q2 ranking in multiple categories, including Embryology, Obstetrics and Gynecology, Reproductive Medicine, and Urology, as of 2023. With an E-ISSN of 2633-8386, Reproduction and Fertility aims to provide a valuable platform for researchers, professionals, and students alike, offering insights into the latest discoveries and innovations in reproductive health. Although currently not an open-access journal, it remains committed to disseminating important findings that can influence clinical practices and policy-making worldwide. Operating from its headquarters in Bristol, United Kingdom, the journal serves as an essential resource for anyone invested in understanding and improving reproductive health outcomes through rigorous academic research.

Welcome to the European Journal of Obstetrics & Gynecology and Reproductive Biology, a premier publication dedicated to advancing the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier, this journal has been a vital resource since its inception in 1971, continuing to provide high-quality, peer-reviewed research through 2024 and beyond. With an impressive impact factor and recognized in the Q2 quartile for both obstetrics and gynecology, as well as reproductive medicine, it ranks among the top journals in its field, being positioned at #59 out of 209 in Obstetrics and Gynecology and #29 out of 90 in Reproductive Medicine. Though not currently an Open Access journal, it remains committed to disseminating valuable findings to enhance clinical practice and facilitate further research. Researchers, professionals, and students can expect insightful articles, comprehensive reviews, and pioneering studies that significantly impact women's health and reproductive biology.

SEMINARS IN REPRODUCTIVE MEDICINE is a leading peer-reviewed journal dedicated to exploring the complexities of human reproduction, offering insightful perspectives that encompass advances in reproductive endocrinology, obstetrics, and gynecology. Published by THIEME MEDICAL PUBL INC, this esteemed journal holds a notable spot in multiple Scopus categories, ranking 21st in Reproductive Medicine and 38th in Obstetrics and Gynecology, with an impressive impact in the Q1 and Q2 quartiles. With its commitment to high-quality research and clinical implications, the journal serves as a vital resource for practitioners, researchers, and students alike, fostering an environment of innovation and collaboration in the rapidly evolving reproductive health landscape. SEMINARS IN REPRODUCTIVE MEDICINE also offers convenient open access options, ensuring that its contributions are readily available to the global academic community. For over two decades, from its establishment in 1999 to the present, it has retained a pivotal role in disseminating critical findings that inform both clinical practice and future research efforts.

The Journal of Assisted Reproduction and Genetics, published by Springer/Plenum Publishers, serves as a pivotal platform for innovative research and advancements in the fields of reproductive medicine, genetics, and developmental biology. With an impact factor that positions it within the upper echelon of its categories—including Q1 rankings in Obstetrics and Gynecology and Reproductive Medicine—this journal plays a critical role in disseminating high-quality, peer-reviewed studies that significantly influence clinical practices and research directions. Renowned for its commitment to enhancing understanding in areas such as assisted reproductive technologies, genetic screening, and reproductive health, the journal attracts contributions from leading experts worldwide. With a broad scope encompassing original research, case studies, and comprehensive reviews, the Journal of Assisted Reproduction and Genetics continues to be an essential resource for researchers, healthcare professionals, and students dedicated to the advancement of reproductive sciences.

MOLECULAR HUMAN REPRODUCTION, published by Oxford University Press, is a pivotal journal dedicated to advancing the field of reproductive biology. Since its inception in 1995, the journal has been recognized for its rigorous peer-reviewed research and substantial contributions to the understanding of molecular mechanisms underlying human reproduction. With an impressive impact factor and ranked within the top tiers (Q1 and Q2) across diverse categories including Embryology, Obstetrics and Gynecology, and Reproductive Medicine, it stands as an essential resource for researchers, healthcare professionals, and students alike. The journal aims to publish cutting-edge research that explores the complexities of human reproduction at the molecular and cellular levels, fostering a deeper understanding that can be translated into clinical practice. Although it currently operates under a subscription model, the valuable insights and groundbreaking findings featured within its pages continue to influence the trajectory of reproductive health research globally. Located in the heart of Oxford, United Kingdom, the journal remains committed to addressing vital challenges in the field and promoting innovative scientific dialogue.

Human Fertility, published by Taylor & Francis Ltd, is a key academic journal that serves the dynamic fields of medicine, obstetrics and gynecology, and reproductive medicine. Established in 1998 and with converged content extending to 2024, the journal holds a notable Q2 ranking in its respective categories, highlighting its influence and scholarly contributions to current research and practice. With an ISSN of 1464-7273 and an E-ISSN of 1742-8149, it rigorously disseminates studies, reviews, and advancements in human fertility, particularly emphasizing evidence-based practices and innovative techniques. Despite its traditional subscription model, the journal remains vital for researchers, healthcare professionals, and students seeking to foster advancements in reproductive health. Its articles are pivotal in addressing the multifaceted challenges faced in reproductive health and guiding future research trajectories.

Jornal Brasileiro de Reprodução Assistida is a prominent academic journal focusing on the latest advancements in reproductive medicine, published by the Sociedade Brasileira de Reprodução Assistida (SBRA). With an ISSN of 1517-5693 and an E-ISSN of 1518-0557, this journal has established itself as a vital resource for researchers, healthcare professionals, and students in the fields of obstetrics and gynecology. Notably recognized within the Q2 category for Obstetrics and Gynecology, it ranks #91 out of 209 in Scopus, placing it in the 56th percentile among its peers. The journal serves as a platform for disseminating innovative research and clinical practices related to assisted reproduction, fostering collaboration and knowledge sharing among professionals in Brazil and beyond. Although currently not an open-access journal, it remains committed to enhancing the scientific discourse in reproductive health, reflecting its vision of supporting advances in healthcare through rigorous peer-reviewed studies. Explore the pivotal contributions made in this field from 2000 to the present, and stay abreast of transformative developments that are shaping reproductive science.

Andrology, an esteemed journal published by WILEY, is dedicated to advancing the field of reproductive health and medicine. With an ISSN of 2047-2919, this journal spans critical topics in andrology, urology, and endocrinology, reflecting its strong commitment to scholarly excellence and innovation. As a Q1 ranked journal in both Reproductive Medicine and Urology, Andrology boasts impressive Scopus rankings, standing at 6th in Reproductive Medicine and 8th in Urology, placing it in the top 10% of its field. The journal is accessible as an Open Access platform, ensuring that valuable research findings are available to a broader audience. With significant impact evidenced by its categorization in Q2 for Endocrinology and Diabetes and Metabolism, Andrology serves as an essential resource for researchers, clinicians, and students alike, supporting the continued advancement of knowledge and practice in male reproductive health.